NCT07694687

Brief Summary

The goal of this observational study is to learn whether family members can help identify signs of delirium in adult patients who are staying in the intensive care unit. Delirium is a sudden change in attention, thinking, or awareness that can happen during serious illness. The main question it aims to answer is: Can family members notice possible signs of delirium that may not be found during routine ICU delirium screening? Participants will receive their usual medical care. Family members who know the patient well will complete a short delirium assessment called the FAM-CAM after visiting the patient. Nurses will continue to perform routine ICU delirium screening using the ICDSC as part of usual care. The study team will compare the family member's assessment with the nurse's routine assessment to see whether family observations provide additional helpful information. Family members may complete the assessment for up to 3 days while the patient is in the ICU.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
330

participants targeted

Target at P75+ for all trials

Timeline
10mo left

Started Aug 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress18%
Aug 2026Jul 2027

First Submitted

Initial submission to the registry

July 6, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 10, 2026

Completed
22 days until next milestone

Study Start

First participant enrolled

August 1, 2026

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2027

Last Updated

August 10, 2026

Status Verified

August 1, 2026

Enrollment Period

12 months

First QC Date

July 6, 2026

Last Update Submit

August 6, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Overall Agreement Among Family FAM-CAM, Nurse ICDSC, and Professional Research Staff CAM-ICU Assessments

    This outcome will measure the level of agreement among the three assessment methods in the same patient and within the same general time frame.During the ICU phase, paired assessment data will be created according to the pairing rules described for the primary outcome. The results of FAM-CAM, ICDSC, and CAM-ICU will be classified as either "positive" or "negative."Agreement will be evaluated using Cohen's kappa coefficient as the main measure. The overall agreement rate, positive agreement rate, and negative agreement rate will also be reported as additional measures, together with 95% confidence intervals.

    once daily between 3:30 PM and 4:30 PM

Secondary Outcomes (1)

  • Effect of Older Age, Low Education Level, Language or Dialect Communication Barriers, and Family Members' Delirium Knowledge on Assessment Disagreement

    once daily between 3:30 PM and 4:30 PM

Study Arms (1)

Delirium Assessment Using FAM-CAM, ICDSC, and CAM-ICU

In this observational study, participants will not receive any study treatment or experimental intervention. The study procedures include daily delirium assessments and routine clinical data collection. Family members will complete one FAM-CAM assessment each day as soon as possible after the ICU visiting period ends. The bedside nurse will independently complete one ICDSC assessment during the same assessment period and record both the assessment result and the time of completion. A trained member of the research team will conduct one CAM-ICU assessment as the reference assessment, as close as practically possible to the FAM-CAM and ICDSC assessments. All three assessments will be completed within a 1-hour period, and the exact completion time of each assessment will be recorded. All three assessments will be conducted independently, and assessors will remain blinded to the results of the other assessments to minimize mutual influence and assessment bias.

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients in ICU and their primary caregivers

You may qualify if:

  • Patients:
  • Aged 18 years or older.
  • Admitted to the ICU for at least 24 hours.
  • Richmond Agitation-Sedation Scale (RASS) score ≥ -3 at the time of enrollment.
  • Provided written informed consent to participate. When patients were unable to provide consent, consent was obtained from their legal surrogates.
  • Family Members:
  • Aged 18 years or older.
  • Identified as the patient's primary family caregiver.
  • Had visited the patient in the ICU at least once.
  • Were able to understand and communicate in Mandarin.
  • Provided written informed consent and voluntarily agreed to participate.

You may not qualify if:

  • Patients:
  • Persistent coma or deep sedation throughout the ICU stay, defined as Glasgow Coma Scale (GCS) score ≤ 8 or RASS score of -4 or -5.
  • A previously confirmed diagnosis of dementia, a severe psychiatric disorder, or an organic neurological disease.
  • Severe hearing impairment that prevented effective communication or study participation.
  • Family Members:
  • Significant visual, hearing, or cognitive problems that prevented them from understanding the study procedures or completing the study assessments.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zhongshan Hospital, Fudan University

Shanghai, Shanghai Municipality, 200032, China

RECRUITING

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
ICU Head Nurse

Study Record Dates

First Submitted

July 6, 2026

First Posted

July 10, 2026

Study Start

August 1, 2026

Primary Completion (Estimated)

July 31, 2027

Study Completion (Estimated)

July 31, 2027

Last Updated

August 10, 2026

Record last verified: 2026-08

Locations